{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T20:17:20Z","timestamp":1771273040000,"version":"3.50.1"},"reference-count":31,"publisher":"American Chemical Society (ACS)","issue":"8","license":[{"start":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T00:00:00Z","timestamp":1753056000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T00:00:00Z","timestamp":1753056000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T00:00:00Z","timestamp":1753056000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol. Pharmaceutics"],"published-print":{"date-parts":[[2025,8,4]]},"DOI":"10.1021\/acs.molpharmaceut.5c00155","type":"journal-article","created":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T14:14:10Z","timestamp":1753107250000},"page":"4612-4623","source":"Crossref","is-referenced-by-count":2,"title":["A Semimechanistic Ocular Pharmacokinetic Model for ADVM-022 Gene Therapy Describing the Dose-Exposure Relationship in Monkeys and the Scaling to Human"],"prefix":"10.1021","volume":"22","author":[{"given":"Florian","family":"Hugi","sequence":"first","affiliation":[{"name":"LYO-X AG, Henric Petri Strasse 6, Basel 4051, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jannik","family":"Vollmer","sequence":"additional","affiliation":[{"name":"LYO-X AG, Henric Petri Strasse 6, Basel 4051, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lionel","family":"Renaud","sequence":"additional","affiliation":[{"name":"LYO-X AG, Henric Petri Strasse 6, Basel 4051, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Machacek","sequence":"additional","affiliation":[{"name":"LYO-X AG, Henric Petri Strasse 6, Basel 4051, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"316","published-online":{"date-parts":[[2025,7,21]]},"reference":[{"key":"ref1\/cit1","doi-asserted-by":"publisher","DOI":"10.1038\/nm1010-1107"},{"key":"ref2\/cit2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ohc.2006.05.009"},{"key":"ref3\/cit3","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1H316"},{"key":"ref4\/cit4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2012.09.006"},{"key":"ref5\/cit5","unstructured":"Schaefer-Swale, K. Non-Clinical Data Support Efficacy and Tolerability of a Human Equivalent Dose of 6E10 vg\/eye of ADVM-022 for the Treatment of Neovascular Age-Related Macular Degeneration; Poster presented at the American Society of Gene & Cell Therapy (ASGCT) 25th Annual Meeting; Adverum Biotechnologies, 2022 https:\/\/adverum.com\/wp-content\/uploads\/\/11\/ASGCT-2022_ADVM-022-6E10-Poster_FINAL_05-17-22b.pdf. (accessed September 28, 2024)."},{"key":"ref6\/cit6","first-page":"790","volume":"64","author":"Xue K.","year":"2023","journal-title":"Invest. Ophthalmol. Visual Sci."},{"key":"ref7\/cit7","doi-asserted-by":"publisher","DOI":"10.1089\/jop.2021.0001"},{"key":"ref8\/cit8","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtm.2020.06.007"},{"key":"ref9\/cit9","doi-asserted-by":"publisher","DOI":"10.1167\/tvst.10.1.34"},{"key":"ref10\/cit10","unstructured":"Kiss, S.; On Behalf of the OPTIC Investigators.  Improved Anatomical Outcomes in ADVM-022 Treated Subjects Relative to Standard-of-Care Bolus Anti-VEGF Therapy: Results From the Phase 1 Study of Intravitreal (IVT) Gene Therapy With ADVM-022 for Neovascular AMD (OPTIC Trial); Poster presented at the Macula Society Annual Meeting; Adverum Biotechnologies, 2022 https:\/\/adverum.com\/wp-content\/uploads\/\/09\/Macula-Society-OPTIC-2e11-NAbs-03-Jun-2022-Final.pdf. (accessed September 28, 2024)."},{"key":"ref11\/cit11","doi-asserted-by":"publisher","DOI":"10.1016\/j.xphs.2023.10.005"},{"key":"ref12\/cit12","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.2c00555"},{"key":"ref13\/cit13","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-023-00867-6"},{"key":"ref14\/cit14","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.2374"},{"key":"ref15\/cit15","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics16010138"},{"issue":"7","key":"ref16\/cit16","first-page":"1792-F0341","volume":"63","author":"Wood E.","year":"2022","journal-title":"Invest. Ophthalmol. Visual Sci."},{"key":"ref17\/cit17","doi-asserted-by":"publisher","DOI":"10.1007\/s40259-023-00629-y"},{"key":"ref18\/cit18","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-023-00842-1"},{"issue":"2","key":"ref19\/cit19","first-page":"112","volume":"39","author":"Grishanin R.","year":"2023","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"ref20\/cit20","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.15-17279"},{"key":"ref21\/cit21","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.7b00164"},{"issue":"5","key":"ref22\/cit22","first-page":"1248","volume":"30","author":"Grishanin R.","year":"2022","journal-title":"Mol. Ther."},{"key":"ref23\/cit23","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2014-305252"},{"key":"ref24\/cit24","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000002566"},{"key":"ref25\/cit25","doi-asserted-by":"publisher","DOI":"10.1007\/s10637-019-00888-z"},{"key":"ref26\/cit26","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.05-0647"},{"key":"ref27\/cit27","doi-asserted-by":"publisher","DOI":"10.1097\/01.ijg.0000146361.15163.ea"},{"key":"ref28\/cit28","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2016.111"},{"key":"ref29\/cit29","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101524"},{"key":"ref30\/cit30","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-56462-3"},{"issue":"7","key":"ref31\/cit31","first-page":"5323","volume":"65","author":"Liu S.","year":"2024","journal-title":"Invest. Ophthalmol. Visual Sci."}],"container-title":["Molecular Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.molpharmaceut.5c00155","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.molpharmaceut.5c00155","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T08:12:23Z","timestamp":1754295143000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/doi\/10.1021\/acs.molpharmaceut.5c00155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,21]]},"references-count":31,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8,4]]}},"alternative-id":["10.1021\/acs.molpharmaceut.5c00155"],"URL":"https:\/\/doi.org\/10.1021\/acs.molpharmaceut.5c00155","relation":{},"ISSN":["1543-8384","1543-8392"],"issn-type":[{"value":"1543-8384","type":"print"},{"value":"1543-8392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,21]]}}}